Culturally Responsive Community Driven Substance Use Recovery for Black and Latinx Population
NCT ID: NCT05260047
Last Updated: 2025-06-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
525 participants
INTERVENTIONAL
2022-07-20
2026-10-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preventing Drug Use in Low Income Clinic Populations
NCT01942876
Harm Reduction Services
NCT05776316
Brief Intervention by Community Health Workers for Unhealthy Drinking in Latinos
NCT03301064
Brief Therapies for Problem Gambling Substance Abusers
NCT00685048
Testing a Promising Treatment for Youth Substance Abuse in a Community Setting
NCT02130479
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The specific aims are:
Specific Aim 1: To evaluate the impact of Imani + a church-based telehealth Medicine Assisted Treatment option (Imani + CTM) compared to Imani + Traditional MAT referral and linkage option (Imani + MAT R\&L) on medication for addiction treatment initiation and engagement.
Specific Aim 2: To assess whether there are changes in substance use over time for Imani+ CTM compared to Imani + Traditional MAT R\&L.
Specific Aim 3: To evaluate potential mediators and moderators (e.g., choice, SDOH) of improvements in primary SUD outcomes (initiation, engagement, and decreased substance use).
Exploratory Aim 1: To assess differences in the 7 domains of citizenship and 8 dimensions of wellness (social determinants of health) comparing those enrolled in a MAT condition to those NOT enrolled in a MAT condition.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
IMANI BREAKTHROUGH
Participants will participate in 24-week IMANI weekly groups
IMANI
For the intervention, the study will introduce and offer Medication Assisted Treatment. Those participants wishing to receive MAT will be randomized to one of two intervention IMANI + church-based telehealth MAT or IMANI + Traditional MAT + Referral and Linkage. Those who do not wish to partake of MAT services will remain in the IMANI alone.
IMANI BREAKTROUGH + church-based telehealth MAT option (IMANI + CTM)
Participants will participate in the 24-week Imani weekly group. During weeks 1-4 participants will received education on MAT. Those participants randomized will receive the IMANI weekly group as well as a church based telehealth Medication Assisted Treatment option. The church based telehealth MAT will consist of participants assigned to receive MAT from addiction treatment providers via telehealth. Telehealth sessions will be provided in the church.
IMANI
For the intervention, the study will introduce and offer Medication Assisted Treatment. Those participants wishing to receive MAT will be randomized to one of two intervention IMANI + church-based telehealth MAT or IMANI + Traditional MAT + Referral and Linkage. Those who do not wish to partake of MAT services will remain in the IMANI alone.
Telehealth MAT
Describe what is the Telehealth MAT briefly
IMANI BREAKTHROUGH + Traditional MAT plus Referral and Linkage
Participants will participate in the 24-week Imani weekly group. During weeks 1-4 participants will received education on MAT. Those participants randomized will receive the IMANI weekly group as well as Traditional MAT services with Referral and Linkage to services. Participants in this arm will be provided a list of referrals and links to community MAT providers. They will choose their providers.
IMANI
For the intervention, the study will introduce and offer Medication Assisted Treatment. Those participants wishing to receive MAT will be randomized to one of two intervention IMANI + church-based telehealth MAT or IMANI + Traditional MAT + Referral and Linkage. Those who do not wish to partake of MAT services will remain in the IMANI alone.
Traditional MAT plus Referral and Linkage
Describe what he traditional MAT plus referral and linkage briefly
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
IMANI
For the intervention, the study will introduce and offer Medication Assisted Treatment. Those participants wishing to receive MAT will be randomized to one of two intervention IMANI + church-based telehealth MAT or IMANI + Traditional MAT + Referral and Linkage. Those who do not wish to partake of MAT services will remain in the IMANI alone.
Telehealth MAT
Describe what is the Telehealth MAT briefly
Traditional MAT plus Referral and Linkage
Describe what he traditional MAT plus referral and linkage briefly
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Are interested in reducing substance use.
* Self-identify as living in a geographical area with high overdose case rates
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chyrell Bellamy, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Yale University
Ayana Jordan, PhD.
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Aery Baptist Church
Bridgeport, Connecticut, United States
Principe of Peace Church
Bridgeport, Connecticut, United States
Blackwell Memorial AME Church
Hartford, Connecticut, United States
Iglesia Nuevo Comienzo
Hartford, Connecticut, United States
Spottswood AME
New Britain, Connecticut, United States
Varick Memorial AME Church
New Haven, Connecticut, United States
Yale Program for Recovery and Community Health
New Haven, Connecticut, United States
Casa de Oracion y Adoracion
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Anthony Bennett
Role: primary
Robyn Anderson
Role: primary
Kelcy G Steele
Role: primary
Hector Caraballo
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2000031168
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.